Bixiye
P80-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 4, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2401 - 2410 ee natiijooyinka 3289
Bixiye
P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P79-20 Change in Medical Necessity Criteria to InterQual® for Substance Use Disorder Admissions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P77-20 2021 Medicare Product Acupuncture Benefit Changes
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
QP106-20 CPT Code 99072 Will Not Be Separately Reimbursed
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020
Bixiye
QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020
Bixiye
QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020
Bixiye
QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020